Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01044615 · ClinicalTrials.gov registry record
Advanced Imaging Tools in the Study of Mild Traumatic Brain Injury
A clinical trial, sponsored by Kettering Health Network.
- Completed
- Registry status
- 20
- Enrollment target
NCT01044615: Completed study, sponsored by Kettering Health Network.
NCT01044615 is a clinical trial that has completed, run by Kettering Health Network. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01044615 has completed, sponsored by Kettering Health Network.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
We will utilize a set of imaging modalities including computed tomography (CT), positron emission tomography (PET), and a suite of magnetic resonance imaging (MRI) tools, to investigate the changes in the human brain resulting from mild traumatic brain injury (mTBI).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-12 |
What the finished NCT01044615 record still lists
NCT01044615 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01044615 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01044615 about?
NCT01044615 is a clinical study titled "Advanced Imaging Tools in the Study of Mild Traumatic Brain Injury". We will utilize a set of imaging modalities including computed tomography (CT), positron emission tomography (PET), and a suite of magnetic resonance imaging (MRI) tools, to investigate the changes in the human brain resulting from mild traumatic brain injury (mTBI).
What is the current status of trial NCT01044615?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2010-12.
Who is sponsoring clinical trial NCT01044615?
This trial is sponsored by Kettering Health Network, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia